- Home
- PAYO vs SUPN Comparison
PAYO vs SUPN Comparison
Compare PAYO & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYO
- SUPN
- Stock Information
- Founded
- PAYO 2005
- SUPN 2005
- Country
- PAYO United States
- SUPN United States
- Employees
- PAYO N/A
- SUPN N/A
- Industry
- PAYO EDP Services
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- PAYO Technology
- SUPN Health Care
- Exchange
- PAYO Nasdaq
- SUPN Nasdaq
- Market Cap
- PAYO 2.2B
- SUPN 1.8B
- IPO Year
- PAYO N/A
- SUPN 2012
- Fundamental
- Price
- PAYO $6.78
- SUPN $31.91
- Analyst Decision
- PAYO Strong Buy
- SUPN Hold
- Analyst Count
- PAYO 8
- SUPN 2
- Target Price
- PAYO $10.44
- SUPN $36.00
- AVG Volume (30 Days)
- PAYO 4.3M
- SUPN 460.6K
- Earning Date
- PAYO 05-07-2025
- SUPN 05-06-2025
- Dividend Yield
- PAYO N/A
- SUPN N/A
- EPS Growth
- PAYO N/A
- SUPN N/A
- EPS
- PAYO 0.28
- SUPN 1.11
- Revenue
- PAYO $996,150,000.00
- SUPN $667,997,000.00
- Revenue This Year
- PAYO $4.12
- SUPN N/A
- Revenue Next Year
- PAYO $4.91
- SUPN $8.74
- P/E Ratio
- PAYO $24.18
- SUPN $28.64
- Revenue Growth
- PAYO 14.86
- SUPN 11.82
- 52 Week Low
- PAYO $5.03
- SUPN $25.53
- 52 Week High
- PAYO $11.29
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- PAYO 45.81
- SUPN 47.71
- Support Level
- PAYO $6.77
- SUPN $31.56
- Resistance Level
- PAYO $6.94
- SUPN $32.85
- Average True Range (ATR)
- PAYO 0.19
- SUPN 0.78
- MACD
- PAYO -0.02
- SUPN -0.08
- Stochastic Oscillator
- PAYO 12.37
- SUPN 24.38
About PAYO Payoneer Global Inc.
Payoneer Global Inc is a financial technology company purpose-built to enable the world's small and medium-sized businesses (SMB(s)) to grow and operate their businesses around the world by reliably and securely connecting them to the digital economy. The company started to empower commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.